» Articles » PMID: 39541256

Photoactivatable O-GlcNAc Transferase Library Enables Covalent Chemical Capture of Solvent-Exposed TPR Domain Interactions

Overview
Journal Chembiochem
Specialty Biochemistry
Date 2024 Nov 14
PMID 39541256
Authors
Affiliations
Soon will be listed here.
Abstract

O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) is an essential, stress-sensing enzyme responsible for adding the O-GlcNAc monosaccharide to thousands of nuclear and cytoplasmic proteins to regulate cellular homeostasis. OGT substrates are found in almost all intracellular processes, and perturbations in protein O-GlcNAc levels have been implicated in proteostatic diseases, such as cancers, metabolic disorders, and neurodegeneration. This broad disease activity makes OGT an attractive therapeutic target; however, the substrate diversity makes pan-inhibition as a therapeutic strategy unfeasible. Rather, a substrate-specific approach to targeting is more advantageous, but how OGT chooses its substrates remains poorly understood. Substrate specificity is controlled by the interactions between OGT's non-catalytic tetratricopeptide repeat (TPR) domain, rather than its glycosyltransferase domain. OGT's TPR domain forms a 100 Å superhelical structure, containing a lumenal surface, known as the substrate-binding surface, and a solvent-exposed surface. To date, there are no tools to site-selectively target regions of the domain and differentiate between the two binding surfaces. Here, we developed a library of recombinant OGT constructs containing site-specifically incorporated photoactivatable unnatural amino acids (UAAs) along the solvent-exposed surface of the TPR domain to covalently capture and map OGT's interactome.

References
1.
Wang H, Wang Y, Zhou Y, Wei Y, Yan Y, Zhang Z . Protein O-GlcNAcylation in cardiovascular diseases. Acta Pharmacol Sin. 2022; 44(1):8-18. PMC: 9813366. DOI: 10.1038/s41401-022-00934-2. View

2.
Ramirez D, Yang B, DSouza A, Shen D, Woo C . Truncation of the TPR domain of OGT alters substrate and glycosite selection. Anal Bioanal Chem. 2021; 413(30):7385-7399. PMC: 9647473. DOI: 10.1007/s00216-021-03731-8. View

3.
Bond M, Hanover J . O-GlcNAc cycling: a link between metabolism and chronic disease. Annu Rev Nutr. 2013; 33:205-29. PMC: 10483992. DOI: 10.1146/annurev-nutr-071812-161240. View

4.
Haltiwanger R, Blomberg M, Hart G . Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. J Biol Chem. 1992; 267(13):9005-13. View

5.
Hanover J, Chen W, Bond M . O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle. J Bioenerg Biomembr. 2018; 50(3):155-173. DOI: 10.1007/s10863-018-9751-2. View